Article
Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenström macroglobulinaemia.
British journal of haematology - 1 Aug 2021
Gustine Joshua N, Xu Lian, Yang Guang, Liu Xia, Kofides Amanda, Tsakmaklis Nicholas, Munshi Manit, Demos Maria, Guerrera Maria L, Meid Kirsten, Patterson Christopher J, Sarosiek Shayna, Branagan Andrew R, Hunter Zachary R, Castillo Jorge J, Treon Steven P
Abstract excerpt
CXCR4 mutations impact disease presentation and treatment outcomes in Waldenström macroglobulinaemia (WM). Non-uniform testing for CXCR4 mutations may account for discordant findings in WM clinical trials. We compared two approaches used in these trials for detection of the most common CXCR4 (S338X) variant: targeted next-generation sequencing (NGS) using unselected bone marrow (BM) samples, and combined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
